Clinically, SIRT4 mRNA expression is reduced in several malignancies, including breast, colon, bladder, gastric, ovarian, and thyroid cancers, though SIRT4 loss was particularly pronounced in lung cancer patients (Figure 6). The gene discussed is SIRT4; the disease is lung cancer.